Oncolytics Biotech Inc. (ONC) Rating Reiterated by Royal Bank Of Canada


's stock had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada in a note issued to investors on Thursday, StockTargetPrices.com reports. Oncolytics Biotech opened at 0.27 on Thursday.



from Biotech News